Active, not recruitingNCT07391592

Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

Studying Avascular necrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
MicroPort Orthopedics Inc.
Principal Investigator
Alexander Sah, MD
Sah Orthopaedic Associates, Fremont, California, United States 94538
Intervention
EVOLUTION® NitrX™(device)
Enrollment
100 enrolled
Eligibility
21 years · All sexes
Timeline
20252032

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07391592 on ClinicalTrials.gov

Other trials for Avascular necrosis

Additional recruiting or active studies for the same condition.

See all trials for Avascular necrosis

← Back to all trials